EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vaccinia and Monkeypox Virus-Neutralizing Antibodies in People Living with HIV: A Serological Study in a Orthopoxvirus-Endemic, Low-Income Region in Brazil

Thyago José Silva iD, Ana Gabriella Stoffella-Dutra, Victor Lacerda Gripp iD, Pollyana R C Gorgens iD, Iago José da Silva Domingos iD, Pedro Henrique Bastos E Silva iD, Bruna Caroline Chaves-Garcia, Erna Geessien Kroon iD, Etel Rocha-Vieira iD, Giliane de Souza Trindade, Danilo Bretas de Oliveira

Pathogens · 2025

DOI: 10.3390/pathogens14080733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Thyago José Silva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Doenças Infecciosas e Parasitárias, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina 39100-000, Minas Gerais, Braz…. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Vaccinia virus, Vaccinia, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Instituto Nacional de Ciência e Tecnologia em Poxvírus, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Co-infections of Orthopoxviruses (OPVs), such as vaccinia virus (VACV) and monkeypox virus (MPXV), and the human immunodeficiency virus (HIV) can be associated with severe outcomes. Serro’s dairy region, located in Minas Gerais, southeastern Brazil, is an endemic area for VACV, where zoonotic outbreaks affect rural communities. This epidemiological context is especially relevant for at-risk populations, such as people living with HIV (PLHIV). This study aimed to assess the presence of neutralizing antibodies (NAbs) against OPV in PLHIV in this endemic setting. Serum samples were collected from 177 PLHIV in treatment at the specialized service between December 2021 and August 2022. VACV and MPXV NAbs were measured using the plaque reduction neutralization test (PRNT) and VACV-infected cells. The overall occurrence of OPV NAbs was 27.7%. NAbs were higher in individuals born before 1980 (53.3%) than those born after 1980 (1.1%). Among anti-VACV-seropositive individuals, 40.8% also had MPXV NAbs, suggesting cross-immunity. These findings indicate the circulation of VACV in PLHIV and highlight the increased susceptibility to OPV infections among individuals born after the cessation of smallpox vaccination. The results reinforce the importance of continued surveillance of OPV, especially in endemic regions and vulnerable populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingVaccinia virusVacciniaHIV InfectionsAntibodies, ViralMonkeypox virusMpox, MonkeypoxHumansBrazilMaleAdultFemaleMiddle AgedCoinfectionYoung AdultOrthopoxvirusNeutralization TestsAdolescent

Stichwörter der Autor:innen

cross protectionhuman immunodeficiency virusorthopoxvirusvaccination

Substanzen

Antibodies, NeutralizingAntibodies, Viral

Autor:innen und Institutionen

  • Laboratório de Doenças Infecciosas e Parasitárias, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina 39100-000, Minas Gerais, Brazil.
  • Laboratório de Vírus, Instituto de Ciências Biológicas, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil.

ORCID-Profile: Thyago José Silva, Victor Lacerda Gripp, Pollyana R C Gorgens, Iago José da Silva Domingos, Pedro Henrique Bastos E Silva, Erna Geessien Kroon, Etel Rocha-Vieira

Förderung

  • National Council for Scientific and Technological Development
  • Instituto Nacional de Ciência e Tecnologia em Poxvírus
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Câmara Pox–Ministério da Ciência, Tecnologia e Inovações
  • Fundação de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig)
  • SISGEN
  • Secretaria de Estado de Saúde de Minas Gerais (SES-MG)

Zitieren

APA

Silva, T. J., Stoffella-Dutra, A. G., Gripp, V. L., Gorgens, P. R. C., Domingos, I. J. D. S., Silva, P. H. B. E., Chaves-Garcia, B. C., Kroon, E. G., Rocha-Vieira, E., Trindade, G. S., & Oliveira, D. B. (2025). Vaccinia and Monkeypox Virus-Neutralizing Antibodies in People Living with HIV: A Serological Study in a Orthopoxvirus-Endemic, Low-Income Region in Brazil. Pathogens. https://doi.org/10.3390/pathogens14080733

Vancouver

Silva TJ, Stoffella-Dutra AG, Gripp VL, Gorgens PRC, Domingos IJDS, Silva PHBE, et al. Vaccinia and Monkeypox Virus-Neutralizing Antibodies in People Living with HIV: A Serological Study in a Orthopoxvirus-Endemic, Low-Income Region in Brazil. Pathogens. 2025. doi:10.3390/pathogens14080733

BibTeX
@article{Silva2025,
  author = {Silva, Thyago José and Stoffella-Dutra, Ana Gabriella and Gripp, Victor Lacerda and Gorgens, Pollyana R C and Domingos, Iago José da Silva and Silva, Pedro Henrique Bastos E and Chaves-Garcia, Bruna Caroline and Kroon, Erna Geessien and Rocha-Vieira, Etel and Trindade, Giliane de Souza and Oliveira, Danilo Bretas de},
  title = {Vaccinia and Monkeypox Virus-Neutralizing Antibodies in People Living with HIV: A Serological Study in a Orthopoxvirus-Endemic, Low-Income Region in Brazil},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14080733}
}
Kostenlos starten →